+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 4ay6 | ||||||
---|---|---|---|---|---|---|---|
タイトル | Human O-GlcNAc transferase (OGT) in complex with UDP-5SGlcNAc and substrate peptide | ||||||
![]() |
| ||||||
![]() | TRANSFERASE / GLYCOSYL TRANSFERASE | ||||||
機能・相同性 | ![]() negative regulation of non-canonical inflammasome complex assembly / protein N-acetylglucosaminyltransferase complex / regulation of insulin receptor signaling pathway / protein O-acetylglucosaminyltransferase activity / protein O-GlcNAc transferase / positive regulation of transcription from RNA polymerase II promoter by glucose / cardiac septum development / acetylglucosaminyltransferase activity / regulation of Rac protein signal transduction / regulation of necroptotic process ...negative regulation of non-canonical inflammasome complex assembly / protein N-acetylglucosaminyltransferase complex / regulation of insulin receptor signaling pathway / protein O-acetylglucosaminyltransferase activity / protein O-GlcNAc transferase / positive regulation of transcription from RNA polymerase II promoter by glucose / cardiac septum development / acetylglucosaminyltransferase activity / regulation of Rac protein signal transduction / regulation of necroptotic process / negative regulation of stem cell population maintenance / protein O-linked glycosylation / positive regulation of cGAS/STING signaling pathway / coronary vasculature development / NSL complex / non-canonical NF-kappaB signal transduction / regulation of glycolytic process / RIPK1-mediated regulated necrosis / aorta development / regulation of gluconeogenesis / mitogen-activated protein kinase p38 binding / regulation of synapse assembly / Formation of WDR5-containing histone-modifying complexes / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / Sin3-type complex / positive regulation of stem cell population maintenance / protein serine/threonine phosphatase activity / phosphatidylinositol-3,4,5-trisphosphate binding / hemopoiesis / positive regulation of proteolysis / histone acetyltransferase complex / IRAK2 mediated activation of TAK1 complex / Alpha-protein kinase 1 signaling pathway / IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation / TICAM1,TRAF6-dependent induction of TAK1 complex / heart morphogenesis / positive regulation of lipid biosynthetic process / TRAF6-mediated induction of TAK1 complex within TLR4 complex / mitophagy / JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 / response to nutrient / negative regulation of proteasomal ubiquitin-dependent protein catabolic process / negative regulation of protein ubiquitination / TNFR1-induced NF-kappa-B signaling pathway / positive regulation of TORC1 signaling / activated TAK1 mediates p38 MAPK activation / transforming growth factor beta receptor signaling pathway / lung development / negative regulation of cell migration / positive regulation of translation / protein serine/threonine kinase activator activity / NOD1/2 Signaling Pathway / TAK1-dependent IKK and NF-kappa-B activation / cell projection / cellular response to glucose stimulus / negative regulation of transforming growth factor beta receptor signaling pathway / circadian regulation of gene expression / Regulation of necroptotic cell death / chromatin DNA binding / CLEC7A (Dectin-1) signaling / FCERI mediated NF-kB activation / response to insulin / mitochondrial membrane / Interleukin-1 signaling / protein processing / UCH proteinases / HATs acetylate histones / positive regulation of cold-induced thermogenesis / chromatin organization / molecular adaptor activity / in utero embryonic development / endosome membrane / Ub-specific processing proteases / positive regulation of MAPK cascade / apoptotic process / endoplasmic reticulum membrane / regulation of transcription by RNA polymerase II / positive regulation of DNA-templated transcription / protein-containing complex binding / SARS-CoV-2 activates/modulates innate and adaptive immune responses / glutamatergic synapse / endoplasmic reticulum / negative regulation of transcription by RNA polymerase II / signal transduction / positive regulation of transcription by RNA polymerase II / protein-containing complex / nucleoplasm / nucleus / plasma membrane / cytosol / cytoplasm 類似検索 - 分子機能 | ||||||
生物種 | ![]() | ||||||
手法 | ![]() ![]() | ||||||
![]() | Schimpl, M. / Zheng, X. / Blair, D.E. / Schuettelkopf, A.W. / Navratilova, I. / Aristotelous, T. / Ferenbach, A.T. / Macnaughtan, M.A. / Borodkin, V.S. / van Aalten, D.M.F. | ||||||
![]() | ![]() タイトル: O-Glcnac Transferase Invokes Nucleotide Sugar Pyrophosphate Participation in Catalysis 著者: Schimpl, M. / Zheng, X. / Borodkin, V.S. / Blair, D.E. / Ferenbach, A.T. / Schuettelkopf, A.W. / Navratilova, I. / Aristotelous, T. / Albarbarawi, O. / Robinson, D.A. / Macnaughtan, M.A. / Van Aalten, D.M.F. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 551.8 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 453.7 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 1.4 MB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 1.5 MB | 表示 | |
XML形式データ | ![]() | 101 KB | 表示 | |
CIF形式データ | ![]() | 132.8 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | ![]()
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | ![]()
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | ![]()
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
単位格子 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
非結晶学的対称性 (NCS) | NCSドメイン:
NCSドメイン領域:
NCS oper:
|
-
要素
#1: タンパク質 | 分子量: 80974.508 Da / 分子数: 4 断片: TPR (TRUNCATED) AND CATALYTIC DOMAIN, RESIDUES 197-915 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() ![]() #2: タンパク質・ペプチド | 分子量: 1309.403 Da / 分子数: 4 / 断片: RESIDUES 389-401 / 由来タイプ: 合成 / 由来: (合成) ![]() #3: 化合物 | ChemComp-SO4 / #4: 化合物 | ChemComp-12V / ( Has protein modification | N | 非ポリマーの詳細 | SULFATE ION (SO4): FROM CRYOPROTEC | 配列の詳細 | SYNTHETIC PEPTIDE COVERING RESIDUES 398-401 WITH SER395 REPLACED BY 3-AMINO-ALANINE, DNP ACCORDING ...SYNTHETIC PEPTIDE COVERING RESIDUES 398-401 WITH SER395 REPLACED BY 3-AMINO-ALANINE, DNP ACCORDING TO THE PDB LIGAND DICTIONARY | |
---|
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 4.75 Å3/Da / 溶媒含有率: 74.08 % / 解説: NONE |
---|---|
結晶化 | pH: 9.3 / 詳細: 1.45 M K2HPO4, 10 MM EDTA, 1 % XYLITOL, pH 9.3 |
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: ![]() ![]() ![]() |
検出器 | タイプ: ADSC QUANTUM 315 / 検出器: CCD / 日付: 2011年9月8日 |
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.873 Å / 相対比: 1 |
反射 | 解像度: 3.3→40 Å / Num. obs: 91074 / % possible obs: 98.2 % / Observed criterion σ(I): 2 / 冗長度: 2.2 % / Rmerge(I) obs: 0.13 / Net I/σ(I): 7.7 |
-
解析
ソフトウェア | 名称: REFMAC / バージョン: 5.6.0117 / 分類: 精密化 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: OTHER 開始モデル: NONE 解像度: 3.3→40 Å / Cor.coef. Fo:Fc: 0.87 / Cor.coef. Fo:Fc free: 0.822 / SU B: 23.864 / SU ML: 0.383 / 交差検証法: THROUGHOUT / ESU R: 3.781 / ESU R Free: 0.451 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. RESIDUES 715-718 AND 747-761 ARE DISORDERED
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 47.914 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 3.3→40 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
|